Abstract
The accumulation of homocysteine (Hcy) during chronic kidney failure (CKD) can exert toxic effects on the glomeruli and tubulo-interstitial region. Among the potential mechanisms, the formation of highly reactive metabolite, Hcy thiolactone, is known to modify proteins by N-homocysteinylation, leading to protein degradation, stress and impaired function. Previous studies documented impaired nitric oxide production and altered caveolin expression in hyperhomocysteinemia (HHcy), leading to endothelial dysfunction. The aim of this study was to determine whether Hhcy homocysteinylates endothelial nitric oxide synthase (eNOS) and alters caveolin-1 expression to decrease nitric oxide bioavailability, causing hypertension and renal dysfunction. We also examined whether hydrogen sulfide (H2S) could dehomocysteinylate eNOS to protect the kidney. WT and Cystathionine β-Synthase deficient (CBS+/−) mice representing HHcy were treated without or with sodium hydrogen sulfide (NaHS), a H2S donor (30 µM), in drinking water for 8 weeks. Hhcy mice (CBS+/−) showed low levels of plasma H2S, elevated systolic blood pressure (SBP) and renal dysfunction. H2S treatment reduced SBP and improved renal function. Hhcy was associated with homocysteinylation of eNOS, reduced enzyme activity and upregulation of caveolin-1 expression. Further, Hhcy increased extracellular matrix (ECM) protein deposition and disruption of gap junction proteins, connexins. H2S treatment reversed the changes above and transfection of triple genes producing H2S (CBS, CSE and 3MST) showed reduction of vascular smooth muscle cell proliferation. We conclude that during Hhcy, homocysteinylation of eNOS and disruption of caveolin-mediated regulation leads to ECM remodeling and hypertension, and H2S treatment attenuates renovascular damage.
Similar content being viewed by others
Introduction
Hyperhomocysteinemia (Hhcy) is frequently seen in patients with chronic kidney disease (CKD) and recent studies implicate Hhcy in the pathophysiology of glomerulosclerosis and interstitial fibrosis, leading to progressive decline in function1,2. Hhcy causes arteriolar constriction, arterial stiffness and endothelial damage3,4. Impaired vascular response during Hhcy is attributed to decreased bioavailability of nitric oxide (NO). In the vasculature, NO is produced from L-arginine mainly by endothelial nitric oxide synthase (eNOS). Hhcy signals the formation of Hcy thiolactone and protein modifications known as homocysteinylation that damage proteins resulting in decreased biological activity. However, it is not known whether homocysteinylation of eNOS occurs during Hhcy.
The generation of NO is dependent on diverse agonists that activate eNOS. In the endothelial cells, eNOS is associated with special flask-shaped invaginations of plasmalemma of terminally differentiated cells called caveolae. Caveolin is a membrane protein in the caveolae which acts as a scaffold for proteins and lipids5. Three types of caveolin (Cav) have been described. Caveolin-1 and -2 are widely expressed in several tissues including kidney6,7,8 whereas caveloin-3 is exclusive to myocytes9. eNOS is a Ca2+/calmodulin dependent enzyme and its activity is regulated by its interaction with caveolin. When eNOS is bound to caveolin-1, the enzyme activity is attenuated whereas its dissociation from caveolin-1 increases enzyme function5. The effect of Hhcy on the expression and interaction between caveolin-1 and eNOS remains unknown.
In the body, homocysteine is metabolized mainly by the enzymes, cystathionine-β-synthase, cystathionine-γ-lyase, and 3-mercaptopyruvate sulfurtransferase (CBS, CSE and 3-MST respectively). This transsulfuration pathway yields cysteine and hydrogen sulfide (H2S). H2S is a gasotransmitter known to have multiple functions including regulation of vascular tone, neuromodulation, anti-oxidant and as an anti-inflammatory molecule10,11. A reduction of H2S producing enzymes and thus H2S has been implicated in animal model of CKD and clinical study12,13. Low plasma H2S has also been linked to decreased glomerular function and increased cardiac risk in CKD patients14. In contrast, supplementation of H2S has been shown to be beneficial in several studies15,16,17,18. Some of the beneficial effects of H2S are attributed to the activation of KATP (ATP-sensitive K+) channels or scavenging free radicals19. Recently, it has been speculated whether H2S is involved in posttranslational protein modification for some of its biological effects20. It is possible that H2S may modify the course of protein-S-S bridge formation and reverse homocysteinylation of proteins such as eNOS.
The aim of the present study was to investigate whether homocysteinylation of eNOS and disruption of caveolin-mediated eNOS regulation leads to hypertension and renal dysfunction. Further, we investigated whether H2S supplementation dehomocysteinylates eNOS and reduces vascular smooth muscle cell proliferation and extracellular matrix protein deposition to protect the kidney from Hhcy mediated injury.
Results
Plasma H2S, renal perfusion and glomerular filtration rate (GFR) is reduced during hyperhomocysteinemia
Plasma Hcy was measured by HPLC (Fig. 1A). Plasma Hcy was increased more than two-fold in CBS+/− mice compared to WT mice (Fig. 1A). In addition, CBS+/− mice had low levels of plasma H2S compared to WT groups (Fig. 1B). NaHS supplementation reduced plasma Hcy levels in CBS+/− mice and increased plasma H2S levels (Fig. 1A,B respectively). Plasma H2S increased in WT mice treated with NaHS (Fig. 1B).
Hhcy decreases plasma H2S level and glomerular filtration rate (GFR) and H2S treatment improves GFR. Plasma Hcy was measured by HPLC and GFR by FITC Inulin method. (A) Plasma Hcy levels, (B) Plasma H2S levels and (C) Glomerular filtration rate (GFR), (D) H2S reduces systolic BP in hyperhomocysteinemic (CBS+/−) mice. Values are mean ± SEM, n = 7/group. *p < 0.05 vs. CBS+/− mice without H2S treatment, †p < 0.05 vs. WT groups, ‡p < 0.05 vs. WT (control).
FITC-Inulin clearance showed reduction of GFR in CBS+/− mice compared to WT groups without or with H2S treatment (Fig. 1C). Following H2S treatment, GFR returned to normal in CBS+/− mice suggesting recovery of renal function (Fig. 1C). GFR was not affected by H2S in WT mice.
At 12 weeks of age, there was no difference in systolic blood pressure (SBP) between the groups. CBS+/− mice exhibited progressive increase in SBP commencing at 16 weeks until the end-point of the experiment (20 wks) compared to WT mice (Fig. 1D). SBP was attenuated following H2S treatment in CBS+/− mice (Fig. 1D). There was no difference in the baseline SBP in WT and CBS+/− mice. H2S treatment did not affect the SBP in WT mice.
Laser Doppler flowmetry was used to measure red blood cell flux (No. of RBCs × velocity) as an index of microvascular blood flow in the renal cortex. CBS+/− mice showed lower renal flux units compared to WT groups reflecting reduced perfusion (Fig. 2A, black arrow). H2S supplementation restored normal perfusion in CBS+/− mice (Fig. 2A,B). There was no difference renal flux units in WT groups without or with H2S treatment (Fig. 2A,B).
Hhcy reduces renal cortical blood flow. (A) Laser Doppler flowmetry line trace showing renal blood flow (blue line, black arrow) in the kidney. Black trace, is from aorta, red trace from renal artery and pink trace from renal vein. (B) Flux unit change from WT. Flux units = No. of RBCs x velocity. It is used as a surrogate for blood flow. n = 6/group, *p < 0.05 vs. CBS+/− mice without H2S treatment, †p < 0.05 vs. WT groups.
Barium angiography revealed decreased vascular density in CBS+/− animals (Fig. 3A). In the renal cortex, CBS+/− mice demonstrated reduction of arcuate (Fig. 3A, red arrows) and interlobular arteries (Fig. 3A, yellow arrows) and the medulla showed decreased interlobar branches (Fig. 3A, white arrows). H2S enhanced vascular density by increasing all branches in the cortex and medulla (Fig. 3A,C) suggesting improved perfusion.
H2S restores Hhcy induced reduced renal cortical vascularity. (A) Representative barium angiogram of left kidneys showing total vascularity. Interlobar arteries are shown by white arrows, arcuate arteries by red arrows and interlobular arteries are shown by yellow arrows, (B) Analysis of renal vessels by Vessel Segmentation and analysis software, (C) Change in total vascular density as % from control mice (WT). n = 6/group, *p < 0.05 vs. CBS+/− mice without H2S treatment, †p < 0.05 vs. WT groups. TV, total vascularity; ILA, interlobular artery; AA, arcuate artery.
Hhcy homocysteinylates eNOS, increases caveolin-1 expression and reduces nitric oxide production
In order to determine whether the protein-amino acid (eNOS-homocysteine) interaction and thus homocysteinylation of eNOS occurred, coimmunoprecipitation experiment was done. In CBS+/− mice, there was a prominent interaction of Hcy with eNOS as observed by eNOS immunoprecipitation followed by Hcy immunodetection which showed high levels of Hcy and low levels of eNOS (Fig. 4A,B). In CBS+/− mice which received H2S, there was significant reduction of Hcy and increased eNOS expression (Fig. 4A,B). In the WT mice without or with H2S, Hcy and eNOS levels were not affected by the treatment (Fig. 4A,B).
H2S increases eNOS activity by caveolin-1 modulation. (A) Immunoprecipitation of endothelial nitric oxide synthase (eNOS, conc.: 2 µg/200 µg of protein) and immunoblotting for eNOS (MW: 140 kDa) and Hcy (MW: 150–160 kDa) in the kidney. Caveolin-1 (Cav-1), (MW: 20 kDa) was quantified in the non-immunoprecipitated sample (cropped immunoblot image), (B) Fold change of proteins eNOS and Hcy, (C) Fold change of Cav-1, (D) Representative images of DAF-2DA fluorescence in MGECs treated without and with Hcy and H2S, and (E) Bar graph showing mean fluorescence ± SEM of DAF-2DA in MGECs. Magnification × 60, scale bar: 20 µm. MW: Molecular weight. n = 5/group, *p < 0.05 vs. CBS+/− mice without H2S treatment, †p < 0.05 vs. WT groups, in vitro experiments, *p < 0.05 vs. Hcy, †p < 0.05 vs. Ctr and H2S.
In the non-immunoprecipitated samples, CBS+/− mice demonstrated increased caveolin-1 expression, which reduced to normal upon H2S supplementation (Fig. 4A,C). Caveolin-1 expression was similar in WT groups (Fig. 4A,C).
Normally upon stimulus, endothelial cells produce NO by the activation of eNOS, which diffuses into the smooth muscle cells to further activate soluble guanylyl cyclase resulting in vessel relaxation. We therefore checked for NO production in MGECs by challenging it with acetylcholine as a measure of eNOS activity. MGECs treated with Hcy only, did not increase NO generation via eNOS stimulation as indicated by low fluorescence with DAF-2DA (Fig. 4D,E). In contrast, acetylcholine enhanced the fluorescence of MGECs treated with Hcy + H2S (Fig. 4D,E). There was no difference in fluorescence in MGECs to H2S treatment alone, which was similar to the control group (Fig. 4D).
H2S antagonizes ECM protein accumulation and smooth muscle cell proliferation
The activation of matrix metalloproteinases (MMPs) and inhibition of their inhibitors, tissue inhibitors of metalloproteinases (TIMPs), lead to excess collagen deposition and allows for vascular smooth muscle cell proliferation in the vasculature.
MMP-2 and -9 are gelatinases which cleave denatured collagen and collagen IV in the basement membrane and MMP-13 degrades fibrillar collagen. In CBS+/− mice, MMP-2, -9, and -13 were upregulated compared to the other groups (Fig. 5A,B). Further, CBS+/− mice demonstrated significant decrease in TIMP-1 and -2 compared to WT groups (Fig. 5A,C). TIMP-4 expression was nonexistent in CBS+/− mice compared to WT groups (Fig. 5A,C). H2S treatment to CBS+/− mice reduced the expression of MMP-2, -9, and -13 and upregulated TIMP-1, -2 and -4 (Fig. 5A–C). In the WT groups, the expression of MMP-2, -9 and -13 and TIMP-1 and -2 was similar without or with H2S treatment (Fig. 5A–C). There was a non-significant decrease in TIMP-4 in WT mice treated with H2S (Fig. 5A,C).
The expressions of MMP/TIMP is altered during Hhcy and H2S restores normal MMP/TIMP balance and reduces collagen deposition. (A) Representative cropped immunoblot images of protein expression of MMP-2, -9 and -13 (MW: 72, 82, and 45 kDa resp.) and TIMP-1, -2 and -4 (MW: 23, 21 and 26 kDa resp.); (B,C) MMP and TIMP fold change, (D,E) Representative gelatin zymogram in MGECs and media and bar graph, (F,G) Zymography of kidney lysate and bar graph. Analysis was done using ImageJ. Values are expressed as fold change. MW: Molecular weight. n = 6/group for Western blot and n = 4/group for zymography, *p < 0.05 vs. CBS+/− mice without H2S treatment, †p < 0.05 vs. WT groups, in vitro experiments, *p < 0.05 vs. Hcy, †p < 0.05 vs. Ctr and H2S.
MMP-9 activity was determined in in vitro experiments using MGECs and lysate from the kidney by gelatin zymography. Hcy treated cell lysate and media showed 1.3 and 2.03-fold increase in MMP-9 activity respectively compared to cells that did not receive any treatment (Fig. 5D,E). H2S treatment reduced MMP-9 activity significantly in cells treated with Hcy but did not affect cells treated with H2S only (Fig. 5D,E). Similarly, kidney lysate from CBS+/− mice showed nearly 2-fold increase in MMP-9 activity compared to WT mice (Fig. 5F,G). MMP-9 activity was mitigated by H2S supplementation (Fig. 5F,G). There was no difference in MMP-9 activity in WT groups (Fig. 5F,G).
Renal fibrosis can occur in all compartments of the kidney. In CBS+/− mice, Masson Trichrome staining revealed increased collagen accumulation in the glomeruli and tubulointerstitium (Fig. 6A, blue arrows). In CBS+/− kidney sections stained with picrosirius red, there was increased type I collagen in the interlobular arteries suggesting arteriosclerosis (Fig. 6B, yellow arrow). Collagen deposition was reduced in all areas following H2S supplementation (Fig. 6A,B). WT mice treated with H2S had similar collagen as that of WT control mice (Fig. 6A,B).
Hhcy increased collagen deposition in the glomeruli, tubulointerstitium and renal cortical arteries. (A) Representative images of Masson Trichrome staining for collagen (blue arrows), (B) Interlobular arteries show increased collagen type I (yellow arrow) with pricrosirius red stain. Magnification ×20 for Masson Trichrome, scale bar: 60 µm, and magnification ×100 for picrosirius red stain, scale bar: 20 µm. n = 5, *p < 0.05 vs. CBS+/− mice without H2S treatment, †p < 0.05 vs. WT groups.
In separate experiments, we examined for vascular smooth cell proliferation (VSMCs) using Ki-67 marker. VSMCs treated with Hcy (75 µM) showed increased Ki-67 expression in the nucleus and decreased following H2S treatment (Fig. 7A,B). Since increased cell proliferation corresponds to increased metabolic activity, we performed MTT assay to confirm the findings above. There was increased absorbance in the VSMCs treated with Hcy (75 µM) alone compared to VSMCs without or with H2S (Fig. 7C) indicating increased metabolic activity. VSMCs treated with Hcy and H2S showed significant reduction in metabolism which was comparable to untreated VSMCs (Fig. 7C).
H2S reduces Hhcy-induced vascular smooth muscle cell proliferation. (A) Fluorescence images of Ki-67 in VSMCs treated without or with Hcy (75 µM) and H2S (30 µM), (B) Quantification of Ki-67, C) MTT assay showing relative VSMCs proliferation to control over 48 h. Magnification ×60, scale bar: 20 µm. n = 4, *p < 0.05 vs. Hcy, †p < 0.05 vs. Ctr and H2S.
The thymidine analog, 5′-bromo-2′-deoxyuridine (BrdU), is incorporated into newly synthesized DNA of replicating cells. Because H2S treatment reduced cell proliferation in Hcy treated VSMCs above, we wanted to test whether H2S treatment to renal artery explants would inhibit VSMCs proliferation in the tunica media. Renal arteries treated with Hcy alone showed increased BrdU immunostaining (Fig. 8A,B). In response to H2S, the arteries that were treated with Hcy showed significant reduction in BrdU fluorescence (Fig. 8A,B) suggesting reduction in VSMCs proliferation.
Triple gene transfection reduces BrdU incorporation in Hhcy mice. Fluorescence image of renal arteries. (A) Triple gene transfection (CBS, CSE and 3MST) and H2S reduces BrdU incorporation in renal artery explants in Hhcy, (B) The number of strong fluorescence signals representing BrdU were analyzed using ImageJ software. Renal artery triple gene transfection: n = 4/group, magnification ×100, scale bar: 100 µm. *p < 0.05 vs. Hcy, †p < 0.05 vs. other groups.
To confirm whether enhancing the endogenous activity of H2S producing enzymes (CBS, CSE and 3MST) would similarly affect VSMCs proliferation in renal arteries, we transfected CBS, CSE and 3MST enzymes ex vivo into renal arteries of WT mice (Fig. 8A,B). As expected, triple gene transfection reduced BrdU incorporation in renal artery rings of WT mice that was treated with Hcy, which was similar to H2S treated WT artery explants (Fig. 8A). There was no change in the expression of BrdU to triple gene transfection in WT artery explant (Fig. 8A,B).
Hhcy increases connexin expression
In addition to intercellular communication, connexins have multiple other roles such as cell signaling, mesangial cell proliferation, blood pressure regulation and as mediators of interstitial fibrosis. We therefore checked for changes in the expression of connexin40 and 43 (Cx40 and 43 respectively), as they are widely expressed in the kidney. In CBS+/− mice, both Cx40 and 43 was highly expressed (Fig. 9A,B). Cx40 was seen in the glomerular and tubular regions (Fig. 9A,B, yellow arrows) and Cx43 localized predominantly to the tubules (Fig. 9A,B, white arrows). H2S supplementation reduced the expression of Cx40 and 43 in CBS+/− mice similar to that seen in WT groups (Fig. 9A,B). H2S treatment did not affect the expression of connexins in WT mice. mRNA quantification for Cx40 and 43 confirmed the findings above (Fig. 9C,D).
H2S downregulates Hhcy-induced increased expression of connexin 40 and 43. (A) Representative images of Cx40 in glomeruli and tubular regions (yellow arrows) and Cx43 in the tubules (white arrows), (B) Mean fluorescence analysis, (C,D) mRNA expression and fold change. Quantification was done using ImageJ software. Magnification × 60, scale bar: 20 µm, n = 6/group, *p < 0.05 vs. CBS+/− mice without H2S treatment, †p < 0.05 vs. WT groups, ‡p < 0.05 vs. WT (control).
Discussion
This study demonstrates that Hhcy reduces hydrogen sulfide (H2S) generation in the kidney and homocysteinylation of eNOS and upregulation caveolin-1 expression together reduce eNOS activity resulting in hypertension. Hhcy associated renal vascular changes include reduction in vascular density, blood flow and increased smooth muscle cell proliferation contributing to impaired renal function. Further, Hhcy-induced MMP-2, -9 and -13 activation, decreased TIMP-1, -2 and -4 and upregulation of gap junction Cx40 and 43 led to dysregulation of ECM metabolism and excess collagen deposition in the glomerular and interstitial regions. We found that H2S supplementation dehomocysteinylates eNOS and reduces caveolin-1 expression to increase eNOS activity thus decreasing blood pressure. In addition, H2S restored normal MMPs/TIMPs axis to reduce glomerular and tubulointerstial sclerosis and improved renal function.
Heterozygous CBS+/− mice have approximately 50% reduction in the CBS enzyme activity and twice the normal plasma Hcy levels, which is clinically significant. Although there has been much debate whether Hhcy contributes to the development of hypertension, emerging evidence suggests it has a significant role. Earlier, a case control study demonstrated that an increase in 5 µM of Hcy was associated with an increase of systolic blood pressure by 0.7 and 1.2 mm of Hg in men and women respectively3. More recently, Yang et al. demonstrated that high levels of homocysteine is associated with hypertension in the presence of comorbidities such as, obesity, dyslipidemia and family h/o of hypertension suggesting a complex relationship between Hhcy and the development of hypertension21. In CKD patients, Hcy and cysteine levels are consistently increased which are also the principal substrates for H2S generation in the body22,23. However, during Hhcy, the serum levels of H2S was found to be significantly decreased in CKD patients24. Several studies have shown that H2S controls vascular tone and reduces blood pressure25,26. Conversely, low levels of H2S has been observed in the kidneys of spontaneously hypertensive rats and after targeted deletion of CSE leading to hypertension25,27. The findings from the present study adds further credence that Hhcy and low levels of H2S contribute to hypertension and renal pathology and supplementation of H2S reduces systolic blood pressure. Further, exogenous H2S supplementation is reported to increase CSE activity, which may therefore reduce plasma Hcy levels as observed in our study28.
Several studies have documented that Hhcy impairs endothelial function in various tissues29,30,31. In renal failure, endothelial and kidney production of NO is impaired32. As a result, there is loss of vascular relaxation, which over time leads to microvascular disruption, decreased blood flow and hypoxia. Capillary rarefaction is a crucial stage in the development of renal damage and fibrosis33,34. In the present study, we observed a reduction in the renal vascularity during Hhcy that was associated with reduction of cortical blood flow and poor renal function. H2S is a well-known vasodilator and direct infusion into the renal artery was shown to increase renal blood flow, GFR, and urinary excretion of sodium and potassium35. Exogenous supplementation of H2S in this study showed increase in the terminal branches of the renal cortex suggesting improved perfusion.
The vascular tone is regulated by the constriction and relaxation of vascular smooth muscle cells which is in part regulated by nitric oxide (NO)36. The endothelium-derived eNOS catalyzes the formation of NO from L-arginine. A decrease in the expression/function of eNOS can therefore affect NO production and thus impair vascular function. Protein homocysteinylation is one of the mechanisms proposed that contributes to Hhcy induced pathology in the kidney37. Further, homocysteinylation of plasma proteins has been documented in uremic patients undergoing hemodialysis38. Several other studies reported homocysteinylation of plasma proteins including albumin, hemoglobin, fibrinogen, and others such as, E-Cadherin, and actin during Hhcy and have been associated with multiple diseases39,40. Since endothelial dysfunction is a feature of Hhcy, we queried whether eNOS was a target of Hhcy. Our findings show that during Hhcy, eNOS is homocysteinylated and its activity is diminished in the kidney.
The eNOS activity in the endothelial cells is regulated by its interaction with caveolin-1. In an in vitro study on human coronary artery endothelial cells, Hhcy was found to downregulate caveolin-1 expression and translocation of eNOS from the caveolar fraction to non-caveolar fractions in the cytoplasm thereby decreasing eNOS availability41. However, in other studies of acute renal insufficiency, a marked increase in caveolin-1 expression was observed in the kidney including aorta and liver42,43. The increased caveolin-1 expression seen in the present study during Hhcy are in agreement with the latter studies above as it also explains decreased eNOS availability due to its binding to eNOS.
Nitric oxide and H2S have vasoregulatory roles in the body and a significant cross talk exists between the two molecules44. In a recent study, Wesseling et al. demonstrated that the gasotransmitters NO, H2S and carbon monoxide (CO) have a complex relationship in the development of hypertension and renal injury45. A reduction of H2S was associated with reduction of NO products but enhanced CO and CO appears to be a mediator between NO and H2S molecules45. In another study, H2S was shown to increase eNOS phosphorylation by activating PI3K/Akt pathway to increase NO production44. In animal models of left ventricle hypertrophy and acute myocardial injury, exogenous H2S increased NO by upregulating eNOS activity to offer cardiac protection46,47. In the present study, exogenous supplementation enhanced eNOS expression and activity in Hhcy and decreased caveolin-1 expression suggesting increased NO bioavailability. NO has been shown to increase CSE expression, thus H2S, in mouse aortic endothelial cells of caveolin1−/− mice to offer protection against atherosclerosis48. The decrease in caveolin-1 expression seen in our study could therefore be due to negative regulation of caveolin-1 by H2S or caveolin-1 translocation from the membrane into the cytoplasm for degradation to enable increased eNOS activation. These possible mechanisms need further exploration.
The disruption of MMP/TIMP axis and excess accumulation of ECM proteins during Hhcy has been demonstrated in several studies including our own49,50,51. The gelatinases, MMP-2 and -9, have increased affinity to collagen IV in the basement membrane. Their inhibitors, TIMPs, are known to have dual role. For example, at low concentration TIMP-2 activates MMP-2 whereas high concentration inhibits MMP-252. TIMP-1 is the main inhibitor of MMP-9 and TIMP-4 has low affinity for MMP-953,54. Therefore, low levels of TIMP-1 and TIMP-4 can upregulate MMP-9 as seen in the present study. Although the gelatinases degrade collagen, because collagen turnover is faster than elastin, oxidatively modified collagen is deposited in the ECM55. In this study, the upregulation of MMPs and collagen deposition led to global fibrosis in the kidney.
An essential component of vascular fibrosis involves VSMC proliferation leading to vessel stiffness. Hhcy promotes VSMCs proliferation in a ROS dependent manner and the use of antioxidant/Hcy lowering agent such as, folic acid, has been shown to inhibit proliferation56,57,58. Further, H2S treatment has been shown to inhibit VSMCs in several in vitro and in vivo studies59,60,61. Zhong et al. demonstrated that exogenous H2S treatment reversed VSMCs proliferation in diabetic rat mesentery62. Du et al. showed that H2S decreased the incorporation of [3H]-thymidine, a cell proliferation marker, in rat aortic VSMCs59. Our in vitro data supports these earlier findings, further, we confirmed inhibition of VSMCs proliferation in the renal artery explants by triple gene transfection which showed decreased BrdU immunofluorescence.
Connexins are gap junction proteins that play a prominent role in maintaining intercellular communication and cell homeostasis. A disruption in their expression can result from oxidative stress and inflammation both of which are associated with Hhcy. Cx40 upregulation was observed in 2 kidney, 1 clip, rat model of hypertension63. Cx43 showed increased expression in the damaged tubular areas of patients suffering from glomerulonephritis64. In another study involving rat model of puromycin-induced nephritis, Cx43 was upregulated in glomerular podocytes however, whether this increase worsens renal injury or is beneficial was not known65. The present study showed similar increase in Cx43 expression in the tubular areas and in the glomeruli of Hhcy mice and was associated with renal damage. Previously, we demonstrated that reduction of H2S in diabetic mice was associated with NMDA-R1 and Cx40 and 43 mediated renal fibrosis66. In the present study, H2S reduced the expression of Cx40 and 43 to mitigate renal injury.
Conclusion
In this study, we show that during Hhcy, homocysteinylation of eNOS and upregulation of caveolin-1 results in decreased eNOS and NO production and a concurrent decrease in H2S leads to impaired vasomotor response, hypertension and poor renal perfusion. In addition, Hhcy disrupts the MMP/TIMP balance and increased Cx40 and 43 expression leading to adverse ECM remodeling. Exogenous H2S supplementation and triple gene therapy (CBS/CSE/3MST) dehomocysteinylated eNOS and reduced caveolin-1 to increase eNOS availability. Finally, H2S inhibited renovascular fibrosis and improved renal function in Hhcy-induced renal injury.
Materials and Methods
C57BL/6J (wild type, WT) and B6.129P2-Cbstm1unc/J (CBS+/−) mice on WT background were purchased from Jackson Laboratory (Bar Harbor, ME). Heterozygous CBS (CBS+/−) mice represent hyperhomocysteinemia (HHcy) model and mice aged 8–12 weeks, weighing 25 g approx. were used in this study. All animals were housed in rooms regulated in temperature (24 °C), 12:12 h light-dark cycle with access to standard chow. All handling of animals were performed in accordance with the guidelines of the animal care and use committee of the Louisville School of Medicine and the Guide for the Care and Use of Laboratory Animals published by NIH, 2011. All the experiments in the study were approved by the Institutional Animal Care and Use Committee (IACUC) at University of Louisville.
WT and CBS+/− mice (n = 7/group) received sodium hydrogen sulfide (NaHS, 30 µM), a H2S donor, in drinking water and their respective controls received plain water for 8 weeks. Because NaHS has short half-life, the water containing NaHS was changed at 3-h interval during the day.
Antibodies and reagents
Sodium hydrogen sulfide (NaHS) was purchased from Sigma Aldrich (St. Louis, MO), eNOS antibody from BD Biosciences (Cat. no.: 610297, San Jose, CA), anti-homocysteine (Cat. no.: AB15154), caveolin-1 (Cat. no.: PA5–37506), connexin-40 (Cat. no.: AB38580) and Connexin-43 (Cat. no.: Ab11370) and Ki-67 (AB15580) antibodies from Abcam (Cambridge, MA), BrdU, MMP-2-9 and -13 (Cat. nos.: MAB4072, AB19167, AB19016 and AB8120 respectively) from Millipore (Burlington, MA), TIMP-1, -2, -4 and GAPDH (Cat. nos.: SC5538, SC6835, SC9375 and SC47724 resp.) and secondary antibodies for mouse and rabbit (SC358920 and SC2004 resp.) from Santa Cruz Biotechnology (Dallas, TX), Masson Trichrome kit from Fisher Scientific, USA, Picrosirius from Polysciences Inc, (Warrington, PA) and MTT assay kit from Cayman Chemical (Ann Arbor, MI).
Blood pressure measurement by DSI telemetry
BP was measured continuously in conscious mice using PhysioTel telemetry system (DSI telemetry, St. Paul, MN) as described previously67. Under tribromoethanol anesthesia, the pressure transmitter, TA11PA-C10, was surgically introduced via the right carotid artery into the aortic arch. After a one-week recovery period, individual mice in cages were placed on receivers, which captured digital signals and relayed it to a computer via DSI matrix. Data was viewed and analyzed by Ponemah v5.20 software (DSI).
High Performance Liquid Chromatography
Plasma homocysteine levels were measured by HPLC as described previously51. Briefly, the following were added to a microcentrifuge tube: 200 µl of plasma, 100 µl of water, 300 µl of 9 M urea (pH 9.0), 50 µl of n-amyl alcohol, and 50 µl 10% NaBH4 solution (wt/vol in 0.1 N NaOH). The solution was incubated at 50 °C for 30 minutes. After cooling to room temperature, 500 µl of 20% trichloroacetic acid was added to precipitate protein. Samples were centrifuged at 12,000 g for 5 minutes. and the supernatant was collected after passing through 0.22 µm filter. The sample was used for HPLC analysis. The mobile phase solution was a mixture of 0.1 M monochloroacetic acid and 1.8 mM octylsulfate in HPLC grade water at pH 3.2. The constant flow rate of isocratic solvent was 0.8 ml/minute. A Shimadzu Class-VP 5.0 chromatograph (Shimadzu, Columbia, MD) system was used to analyze samples.
Plasma H2S measurement
Plasma H2S levels were measured as described before68. Briefly, freshly collected plasma (100 µL) was mixed with PBS (350 µL) and Zinc acetate (250 µL) and sealed immediately. To this mixture, N,N-dimethyl-p-phenylenediamine sulfate (20 mM, 133 μL) in 7.2 M HCl, and FeCl3 (30 mM, 133 μL) in 1.2 M HCl was added and incubated at 37 °C for 45 minutes. The reaction was terminated by adding Trichloroacetic acid solution (10% w/v, 250 μL). After centrifugation (×2,700 g for 5 minutes), aliquots were transferred to a 96-well plate and absorbance was read at 670 nm using Spectramax M2e (Molecular devices, CA). The values were calculated by using a standard curve of known concentrations.
Laser Doppler flowmetry and Barium angiography
Renal cortical blood flow was measured using Speckle Contrast Imager (MoorFLPI, Wilmington, DE) as described before69. The Moor FLPI speckle contrast imager uses a diverging infrared laser beam to illuminate the tissue of interest to produce an interference pattern called as ‘laser speckle’. A charge couple device sensor in the camera captures the light and the inbuilt software processes the high and low contrast areas to yield video and trace lines. The flux units are automatically calculated by the software as No. of RBCs × velocity. The left kidney was exposed posteriorly and positioned approximately 15 cm from the camera which was focused on the kidney, renal vessels and aorta. High-speed images with a display rate of 25 Hz including line traces were obtained for 2 minutes.
Renal angiography was done by infusing Barium sulfate solution in 50 mM of TRIS buffer (100 mg/mL at pH 5.0) through the renal artery and imaged using KODAK in vivo Imaging System FX Pro (Molecular Imaging System; www.Bruker.com)69. Analysis was done using Vessel Segmentation and Analysis software (http://www.isip.uni-luebeck.de/?id=150)69.
Glomerular filtration rate (GFR) measurement
GFR was measured by FITC-Inulin clearance method70. Mini osmotic pumps (Alzet Model 2001D, Cupertino, CA) were loaded with 200 µL of dialysed 5% FITC-Inulin. Under 2,2,2-Tribromoethanol anesthesia, osmotic pumps were implanted in the abdominal cavity. After 2 h recovery, the mice were placed individually in metabolic cages and urine was collected over 24 h period including blood samples. Since pH affects the FITC fluorescence, urine and plasma samples were buffered to pH 7.4 with 500 mM HEPES. Separate standard curves were prepared for urine and plasma as described before71. Samples were transferred to 96-well plate and fluorescence measured using SpectraMax M2e (San Jose, CA) with excitation set at 485 nm and emission at 538 nm. Inulin clearance (GFR) was calculated as urinary FITC-Inulin excretion rate (Fluorescence counts/24 h) divided by plasma FITC-Inulin concentration (Fluorescence counts/µL).
Immunoprecipitation analysis
Protein was extracted from whole kidney lysate and pre cleared with 20 μL of Protein A/G Plus-Agarose beads and 1 μg mouse IgG (Cat. no. SC2003, and SC2025 resp., Santa Cruz Biotechnology, Dallas, TX) at 4 °C for 30 minutes. The pre cleared lysate was incubated overnight with IgG1, κ eNOS mouse monoclonal antibody (2 μg/200 μg of protein, Cat. no.: 610297, BD Biosciences, San Jose, CA) at 4 °C with rotation. Protein A/G agarose beads were then added to the lysate and incubated for 4 h at 4 °C under rotation to capture the immune complex. After washing with lysis buffer, the immune complex was eluted at 50 °C for 10 minutes using SDS buffer and subjected to Western blot analysis with anti-eNOS (Cat. no.: 610297, dil.: 1:2500, BD Biosciences) and anti Hcy antibodies (Cat. no.: AB15154, dil.: 1:1000, Abcam). Secondary antibodies (rabbit anti-mouse IgG-HRP, Cat. no.: SC358920; and goat anti-rabbit IgG-HRP, Cat. no.: SC2004 respectively) were used at 1:1000 dilution and bands were detected using chemiluminescence (Luminata Forte, BioRad). Band intensity was calculated using imageJ software (https://imagej.nih.gov/ij/).
Histology
Formalin fixed, paraffin embedded kidney sections (5 µm thickness) were stained for collagen using Masson Trichrome kit (Thermo Scientific) and Picrosirius red kit (Polysciences, Warrington, PA) following manufacturer’s instructions. Images were captured using Olympus Fluoview1000 microscope (B&B Microscope Ltd, PA).
Western blotting
The effect of HHcy and H2S on the expression of eNOS, Caveolin-1, MMP-2, -9, -13 (Dilution: 1:1000 for all) and TIMP-1, -2 and -4 (Dilution: 1:300, 1:500 and 1:500 resp.) were quantified by standard Western blot72.
Immunohistochemistry
Immunostaining was done for connexin-40 and -43, using 5 μm thickness frozen kidney sections. Briefly, after fixation with 4% paraformaldehyde, sections were blocked for 45 minutes at room temperature and incubated overnight at 4 °C with primary antibodies for Cx-40 and -43 (dilution: 1:100). Goat anti-rabbit IgG secondary antibody, Alexa Fluor 594 (Cat. no.:A-11012, dilution: 1:500) was applied for 90 minutes at room temperature. Images were captured by Olympus FluoView1000 (B&B Microscope Ltd., PA). Mean fluorescent intensity was quantified using ImageJ software (https://imagej.nih.gov/ij/).
Nitric oxide production
4,5-Diaminofluorescein diacetate (DAF-2DA) was used to measure nitric oxide levels in in vitro experiments. Mouse glomerular endothelial cells (MGECs) were purchased from Cell Biologics (Chicago, IL) and cultured using endothelial cell media (M1168-kit, Cell Biologics, Chicago, IL). For imaging study, cells were cultured in 8-well chamber slides (Nunc, ThermoFisher) to yield a density of 3 × 103 cells/well. Cells were treated without or with H2S (30 µM) followed by Hcy (75 µM). After 48 h, the cells were washed in PBS and incubated with 10 µM of DAF-2DA in a humidified chamber for 15 minutes at 37 °C. Subsequently, cells were challenged with acetylcholine (10−5 M) for 15 minutes. The cells were washed in PBS and images captured by fluorescence microscope (Olympus FluoView1000 (B&B Microscope Ltd., PA) set for excitation at 495 nm and emission at 515 nm.
Cell proliferation studies
3-(4 – 5-methylthiozol-2 – yl)-2.5-diphenyltetrazolium bromide (MTT) assay was done using mouse aortic vascular smooth muscle cells (VSMCs, ATCC, Manassas, VA). Cells were cultured in 96-well culture plates and treated without or with H2S (30 μM) followed by Hcy (75 μM) for 48 h. After washing, wells were incubated with 5 mg/mL (12 mM) of MTT for 4 h at 37 °C. The formazan crystals formed were solubilized by adding solution containing 10% SDS in 0.01 M HCL and incubation for 4 h at 37 °C. Absorbance was read at 570 nm using microplate reader (SpectraMax M2e, Molecular devices, San Jose, CA).
Ki-67 is a nuclear marker for proliferating cells. In a second set of experiments, VSMCs were treated with Hcy and H2S as above and stained with anti-Ki-67.
In separate experiments, renal arteries from WT mice were transfected ex vivo with triple gene (CBS, CSE and 3MST) as described before73. Renal arteries were excised from WT mice (n = 4) and rinsed in ice-cold physiological salt solution. The arteries were cut into 2 mm rings and placed in a 12-well plate containing DMEM F/12 50/50 cell culture media (Mediatech Inc, VA). Arteries were transfected with plasmid containing CBS, CSE and 3MST genes (0.4 μg DNA/cm2 of growth area) or control plasmid without genes using jetPRIME transfection reagent (Polyplus Transfection) following the manufacturer’s instructions. After 6 h, the arteries were mounted on the bottom of plate using Matrigel (BD Biosciences, San Diego, CA) and treated without or with Hcy (75 µM) in fresh growth media. After 48 h, artery rings were fixed with Tissue Tek OCT compound. Sections of 5 μm thickness were cut and stained with 5-bromo-2′-deoxyuridine (BrdU) antibody (Millipore Sigma, MA) and images were captured with Olympus FluoView1000 microscope (B&B Microscope Ltd., PA).
Gelatin Zymography
The proteolytic activity of MMP-9 to HHcy and H2S treatment was detected by gelatin zymography as described previously69.
Statistics
Values are presented as mean ± SEM. Data was analyzed by ANOVA followed by post hoc, Bonferroni correction to identify differences between two groups. Mann-Whitney U test was done for nonparametric data. A ‘p’ value of <0.05 was considered significant.
References
Cao, L. et al. Folic acid attenuates hyperhomocysteinemia-induced glomerular damage in rats. Microvasc Res 89, 146–152, https://doi.org/10.1016/j.mvr.2013.07.002 (2013).
Kumagai, H. et al. Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia. Kidney international 62, 1219–1228, https://doi.org/10.1111/j.1523-1755.2002.kid558.x (2002).
Stehouwer, C. D. & van Guldener, C. Does homocysteine cause hypertension? Clinical chemistry and laboratory medicine: CCLM/FESCC 41, 1408–1411, https://doi.org/10.1515/CCLM.2003.216 (2003).
van Guldener, C. & Stehouwer, C. D. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost 26, 281–289, https://doi.org/10.1055/s-2000-8472 (2000).
Feron, O., Saldana, F., Michel, J. B. & Michel, T. The endothelial nitric-oxide synthase-caveolin regulatory cycle. The Journal of biological chemistry 273, 3125–3128 (1998).
Razani, B., Woodman, S. E. & Lisanti, M. P. Caveolae: from cell biology to animal physiology. Pharmacol Rev 54, 431–467 (2002).
Williere, Y. et al. Caveolin 1 Promotes Renal Water and Salt Reabsorption. Sci Rep 8, 545, https://doi.org/10.1038/s41598-017-19071-6 (2018).
Komers, R. et al. Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney. Diabetes 55, 1651–1659, https://doi.org/10.2337/db05-1595 (2006).
Song, K. S. et al. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. The Journal of biological chemistry 271, 15160–15165 (1996).
Wang, R. Gasotransmitters: growing pains and joys. Trends Biochem Sci 39, 227–232, https://doi.org/10.1016/j.tibs.2014.03.003 (2014).
Zhang, Y. et al. Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases. Molecular and cellular biology 33, 1104–1113, https://doi.org/10.1128/MCB.01215-12 (2013).
Aminzadeh, M. A. & Vaziri, N. D. Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 27, 498–504, https://doi.org/10.1093/ndt/gfr560 (2012).
Zavaczki, E. et al. Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells. Kidney international 80, 731–739, https://doi.org/10.1038/ki.2011.212 (2011).
Kuang, Q. et al. Low Plasma Hydrogen Sulfide Is Associated with Impaired Renal Function and Cardiac Dysfunction. American journal of nephrology 47, 361–371, https://doi.org/10.1159/000489606 (2018).
Han, S. J., Kim, J. I., Park, J. W. & Park, K. M. Hydrogen sulfide accelerates the recovery of kidney tubules after renal ischemia/reperfusion injury. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association 30, 1497–1506, https://doi.org/10.1093/ndt/gfv226 (2015).
Li, L. et al. Hydrogen sulfide reduced renal tissue fibrosis by regulating autophagy in diabetic rats. Mol Med Rep 16, 1715–1722, https://doi.org/10.3892/mmr.2017.6813 (2017).
Hou, C. L. et al. Protective Effects of Hydrogen Sulfide in the Ageing Kidney. Oxid Med Cell Longev 2016, 7570489, https://doi.org/10.1155/2016/7570489 (2016).
Snijder, P. M. et al. Emerging role of gasotransmitters in renal transplantation. Am J Transplant 13, 3067–3075, https://doi.org/10.1111/ajt.12483 (2013).
Stein, A. & Bailey, S. M. Redox Biology of Hydrogen Sulfide: Implications for Physiology, Pathophysiology, and Pharmacology. Redox Biol 1, 32–39, https://doi.org/10.1016/j.redox.2012.11.006 (2013).
Li, Q. & Lancaster, J. R. Jr. Chemical foundations of hydrogen sulfide biology. Nitric oxide: biology and chemistry/official journal of the Nitric Oxide Society 35, 21–34, https://doi.org/10.1016/j.niox.2013.07.001 (2013).
Yang, B. et al. Interactions of homocysteine and conventional predisposing factors on hypertension in Chinese adults. J Clin Hypertens (Greenwich) 19, 1162–1170, https://doi.org/10.1111/jch.13075 (2017).
van Guldener, C. & Stehouwer, C. D. Homocysteine and methionine metabolism in renal failure. Semin Vasc Med 5, 201–208, https://doi.org/10.1055/s-2005-872405 (2005).
Nakanishi, T. et al. Free cysteine is increased in plasma from hemodialysis patients. Kidney international 63, 1137–1140, https://doi.org/10.1046/j.1523-1755.2003.00808.x (2003).
Perez-de-Arce, K., Foncea, R. & Leighton, F. Reactive oxygen species mediates homocysteine-induced mitochondrial biogenesis in human endothelial cells: modulation by antioxidants. Biochem Biophys Res Commun 338, 1103–1109, https://doi.org/10.1016/j.bbrc.2005.10.053 (2005).
Yang, G. et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 322, 587–590, https://doi.org/10.1126/science.1162667 (2008).
Zhao, W., Zhang, J., Lu, Y. & Wang, R. The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener. The EMBO journal 20, 6008–6016, https://doi.org/10.1093/emboj/20.21.6008 (2001).
Ahmad, F. U. et al. Hydrogen sulphide and tempol treatments improve the blood pressure and renal excretory responses in spontaneously hypertensive rats. Ren Fail 36, 598–605, https://doi.org/10.3109/0886022X.2014.882218 (2014).
Ahmad, A. et al. Cystathione gamma lyase/Hydrogen Sulphide Pathway Up Regulation Enhances the Responsiveness of alpha1A and alpha1B-Adrenoreceptors in the Kidney of Rats with Left Ventricular Hypertrophy. Plos one 11, e0154995, https://doi.org/10.1371/journal.pone.0154995 (2016).
Jiang, X. et al. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arteriosclerosis, thrombosis, and vascular biology 25, 2515–2521, https://doi.org/10.1161/01.ATV.0000189559.87328.e4 (2005).
Yan, T. T. et al. Homocysteine impaired endothelial function through compromised vascular endothelial growth factor/Akt/endothelial nitric oxide synthase signalling. Clin Exp Pharmacol Physiol 37, 1071–1077, https://doi.org/10.1111/j.1440-1681.2010.05438.x (2010).
Cianciolo, G. et al. Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First? Cardiorenal Med 7, 255–266, https://doi.org/10.1159/000471813 (2017).
Baylis, C. Nitric oxide deficiency in chronic kidney disease. American journal of physiology. Renal physiology 294, F1–9, https://doi.org/10.1152/ajprenal.00424.2007 (2008).
Kang, D. H. et al. Role of the microvascular endothelium in progressive renal disease. Journal of the American Society of Nephrology: JASN 13, 806–816 (2002).
Chade, A. R. Renal vascular structure and rarefaction. Compr Physiol 3, 817–831, https://doi.org/10.1002/cphy.c120012 (2013).
Xia, M., Chen, L., Muh, R. W., Li, P. L. & Li, N. Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys. J Pharmacol Exp Ther 329, 1056–1062, https://doi.org/10.1124/jpet.108.149963 (2009).
Chen, K., Pittman, R. N. & Popel, A. S. Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective. Antioxidants & redox signaling 10, 1185–1198, https://doi.org/10.1089/ars.2007.1959 (2008).
Jakubowski, H. Homocysteine thiolactone: metabolic origin and protein homocysteinylation in humans. The Journal of nutrition 130, 377S–381S, https://doi.org/10.1093/jn/130.2.377S (2000).
Perna, A. F. et al. Increased plasma protein homocysteinylation in hemodialysis patients. Kidney international 69, 869–876, https://doi.org/10.1038/sj.ki.5000070 (2006).
Jakubowski, H. Pathophysiological consequences of homocysteine excess. The Journal of nutrition 136, 1741S–1749S (2006).
Bossenmeyer-Pourie, C. et al. Early methyl donor deficiency produces severe gastritis in mothers and offspring through N-homocysteinylation of cytoskeleton proteins, cellular stress, and inflammation. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 27, 2185–2197, https://doi.org/10.1096/fj.12-224642 (2013).
Meye, C., Schumann, J., Wagner, A. & Gross, P. Effects of homocysteine on the levels of caveolin-1 and eNOS in caveolae of human coronary artery endothelial cells. Atherosclerosis 190, 256–263, https://doi.org/10.1016/j.atherosclerosis.2006.03.009 (2007).
Mahmoudi, M. et al. In vivo and in vitro models demonstrate a role for caveolin-1 in the pathogenesis of ischaemic acute renal failure. J Pathol 200, 396–405, https://doi.org/10.1002/path.1368 (2003).
Sindhu, R. K., Ehdaie, A., Vaziri, N. D. & Roberts, C. K. Effects of chronic renal failure on caveolin-1, guanylate cyclase and AKT protein expression. Biochimica et biophysica acta 1690, 231–237, https://doi.org/10.1016/j.bbadis.2004.06.013 (2004).
Coletta, C. et al. Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation. Proceedings of the National Academy of Sciences of the United States of America 109, 9161–9166, https://doi.org/10.1073/pnas.1202916109 (2012).
Wesseling, S., Fledderus, J. O., Verhaar, M. C. & Joles, J. A. Beneficial effects of diminished production of hydrogen sulfide or carbon monoxide on hypertension and renal injury induced by NO withdrawal. Br J Pharmacol 172, 1607–1619, https://doi.org/10.1111/bph.12674 (2015).
Polhemus, D. et al. Hydrogen sulfide attenuates cardiac dysfunction after heart failure via induction of angiogenesis. Circ Heart Fail 6, 1077–1086, https://doi.org/10.1161/CIRCHEARTFAILURE.113.000299 (2013).
King, A. L. et al. Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent. Proceedings of the National Academy of Sciences of the United States of America 111, 3182–3187, https://doi.org/10.1073/pnas.1321871111 (2014).
Go, Y. M., Lee, H. R. & Park, H. H(2)S inhibits oscillatory shear stress-induced monocyte binding to endothelial cells via nitric oxide production. Molecules and cells 34, 449–455, https://doi.org/10.1007/s10059-012-0200-5 (2012).
Sen, U. et al. Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure. American journal of physiology. Renal physiology 297, F410–419, https://doi.org/10.1152/ajprenal.00145.2009 (2009).
Yang, Z. Z. & Zou, A. P. Homocysteine enhances TIMP-1 expression and cell proliferation associated with NADH oxidase in rat mesangial cells. Kidney international 63, 1012–1020, https://doi.org/10.1046/j.1523-1755.2003.00825.x (2003).
Pushpakumar, S. B., Kundu, S., Metreveli, N. & Sen, U. Folic acid mitigates angiotensin-II-induced blood pressure and renal remodeling. PloS one 8, e83813, https://doi.org/10.1371/journal.pone.0083813 (2013).
Bernardo, M. M. & Fridman, R. TIMP-2 (tissue inhibitor of metalloproteinase-2) regulates MMP-2 (matrix metalloproteinase-2) activity in the extracellular environment after pro-MMP-2 activation by MT1 (membrane type 1)-MMP. The Biochemical journal 374, 739–745, https://doi.org/10.1042/BJ20030557 (2003).
Greene, J. et al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. The Journal of biological chemistry 271, 30375–30380 (1996).
Liu, Y. E. et al. Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4). The Journal of biological chemistry 272, 20479–20483 (1997).
Camp, T. M., Tyagi, S. C., Senior, R. M., Hayden, M. R. & Tyagi, S. C. Gelatinase B(MMP-9) an apoptotic factor in diabetic transgenic mice. Diabetologia 46, 1438–1445, https://doi.org/10.1007/s00125-003-1200-y (2003).
Au-Yeung, K. K. et al. Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress. Circulation research 94, 28–36, https://doi.org/10.1161/01.RES.0000108264.67601.2C (2004).
Edirimanne, V. E. et al. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats. Can J Physiol Pharmacol 85, 1236–1247, https://doi.org/10.1139/Y07-112 (2007).
Zou, T., Yang, W., Hou, Z. & Yang, J. Homocysteine enhances cell proliferation in vascular smooth muscle cells: role of p38 MAPK and p47phox. Acta Biochim Biophys Sin (Shanghai) 42, 908–915, https://doi.org/10.1093/abbs/gmq102 (2010).
Du, J. et al. The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels 19, 75–80, https://doi.org/10.1007/s00380-003-0743-7 (2004).
Yang, G., Wu, L. & Wang, R. Pro-apoptotic effect of endogenous H2S on human aorta smooth muscle cells. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 20, 553–555, https://doi.org/10.1096/fj.05-4712fje (2006).
Yang, G., Sun, X. & Wang, R. Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 18, 1782–1784, https://doi.org/10.1096/fj.04-2279fje (2004).
Zhong, X. et al. Calcium sensing receptor regulating smooth muscle cells proliferation through initiating cystathionine-gamma-lyase/hydrogen sulfide pathway in diabetic rat. Cell Physiol Biochem 35, 1582–1598, https://doi.org/10.1159/000373973 (2015).
Haefliger, J. A. et al. Connexins 40 and 43 are differentially regulated within the kidneys of rats with renovascular hypertension. Kidney international 60, 190–201, https://doi.org/10.1046/j.1523-1755.2001.00786.x (2001).
Hillis, G. S. et al. Upregulation and co-localization of connexin43 and cellular adhesion molecules in inflammatory renal disease. J Pathol 182, 373–379, doi:10.1002/(SICI)1096-9896(199708)182:4<373::AID-PATH858>3.0.CO;2-B (1997).
Yaoita, E. et al. Up-regulation of connexin43 in glomerular podocytes in response to injury. Am J Pathol 161, 1597–1606 (2002).
Kundu, S., Pushpakumar, S. B., Tyagi, A., Coley, D. & Sen, U. Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9. American journal of physiology. Endocrinology and metabolism 304, E1365–1378, https://doi.org/10.1152/ajpendo.00604.2012 (2013).
Wang, Y., Thatcher, S. E. & Cassis, L. A. Blood Pressure Monitoring Using Radio Telemetry Method in Mice. Methods Mol Biol 1614, 75–85, https://doi.org/10.1007/978-1-4939-7030-8_7 (2017).
Kundu, S., Pushpakumar, S. & Sen, U. MMP-9- and NMDA receptor-mediated mechanism of diabetic renovascular remodeling and kidney dysfunction: hydrogen sulfide is a key modulator. Nitric oxide: biology and chemistry/official journal of the Nitric Oxide Society 46, 172–185, https://doi.org/10.1016/j.niox.2015.02.003 (2015).
Pushpakumar, S. et al. Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice. Journal of hypertension 31, 2270–2281, discussion 2281, https://doi.org/10.1097/HJH.0b013e3283649b33 (2013).
Sen, U. et al. Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis. American journal of nephrology 31, 442–455, https://doi.org/10.1159/000296717 (2010).
Qi, Z. et al. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. American journal of physiology. Renal physiology 286, F590–596, https://doi.org/10.1152/ajprenal.00324.2003 (2004).
Pushpakumar, S. B., Kundu, S., Metreveli, N., Tyagi, S. C. & Sen, U. Matrix Metalloproteinase Inhibition Mitigates Renovascular Remodeling in Salt-SensitiveHypertension. Physiological reports 1, e00063, https://doi.org/10.1002/phy2.63 (2013).
Sen, U. et al. Increased endogenous H2S generation by CBS, CSE, and 3MST gene therapy improves ex vivo renovascular relaxation in hyperhomocysteinemia. American journal of physiology. Cell physiology 303, C41–51, https://doi.org/10.1152/ajpcell.00398.2011 (2012).
Acknowledgements
This study was supported, in part, by NIH grant HL-104103 and DK 104653 to US and AHA grant: 15SDG25840013 to S.P. The funders had no role in study design, data collection and analysis.
Author information
Authors and Affiliations
Contributions
S.P. and U.S. designed research work; S.P. acquired data, performed analysis and wrote the manuscript. S.K. contributed to methods and data acquisition.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Pushpakumar, S., Kundu, S. & Sen, U. Hydrogen Sulfide Protects Hyperhomocysteinemia-Induced Renal Damage by Modulation of Caveolin and eNOS Interaction. Sci Rep 9, 2223 (2019). https://doi.org/10.1038/s41598-018-38467-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-018-38467-6